Melissa Diloreto, APRN
Obstetrics & Gynecology · Newington, CTNPI 1851670913
Payments from drug & device makers
Across 195 payments — averaging $21.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$660
- Astellas Pharma US Inc$419
- Exeltis, USA Inc.$355
- Sumitomo Pharma America, Inc.$283
- Agile Therapeutics, Inc.$260
- Mayne Pharma Commercial LLC$253
- plus $2K from 31 others
What the payments were for
- Food & beverage$3,91392%
- Education$2937%
- Other$331%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 27 | $660 |
| Astellas Pharma US Inc | 10 | $419 |
| Exeltis, USA Inc. | 16 | $355 |
| Sumitomo Pharma America, Inc. | 16 | $283 |
| Agile Therapeutics, Inc. | 13 | $260 |
| Mayne Pharma Commercial LLC | 11 | $253 |
| Merck | 12 | $247 |
| Myovant Sciences Inc. | 17 | $199 |
| Pfizer | 9 | $185 |
| Millicent US Inc | 7 | $159 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $154 |
| Lilly USA, LLC | 7 | $152 |
| Sage Therapeutics, LLC | 6 | $140 |
| Evofem Biosciences, Inc. | 3 | $102 |
| Therapeuticsmd, Inc. | 4 | $86 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| Organon | 4 | $64 |
| Exact Sciences | 3 | $63 |
| Amgen | 2 | $39 |
| Sanofi-aventis U.S. LLC | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Novo Nordisk | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Coopersurgical, Inc. | 1 | $20 |
| Axonics, Inc. | 1 | $20 |
| AstraZeneca | 1 | $20 |
| Upsher-smith Laboratories LLC | 1 | $20 |
| Bayer | 1 | $19 |
| Boehringer Ingelheim | 1 | $19 |
| Baxter Healthcare | 1 | $18 |
| Scynexis, Inc. | 1 | $17 |
| Almatica Pharma LLC | 1 | $16 |
| Redhill Biopharma Inc. | 1 | $16 |
| Welch Allyn | 1 | $15 |
| Avion Pharmaceuticals | 1 | $15 |
| Lupin Inc. | 1 | $14 |
How this compares
$4,239 in reported general payments places this provider in the 90th percentile of 605 obstetrics & gynecology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 16 | $628 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Newington
- Kirsten KerriganNewington$5K
- Jeffrey MihalekNewington$5K
- Alessandro SantinNew Haven$14.1M
- Mark LeondiresNorwalk$1.4M
- Alan FineHartford$974K
- Mary MinkinNew Haven$285K
- Elena RatnerNew Haven$119K
- Frederick RauHartford$89K
- Daniel WellingManchester$63K
- Peter AuerbachGroton$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.